Investment Rating - The report maintains a strong buy recommendation for the company [2] Core Views - The company achieved a revenue of 1.326 billion yuan in 2024, representing a year-on-year growth of 15.02%, while the net profit attributable to shareholders decreased by 5.26% to 104 million yuan [6][9] - The company is expanding into new markets such as 3C electronics, humanoid robots, and commercial aerospace, which are expected to drive future growth [9] Financial Performance Summary - In 2024, the company reported a revenue of 1.326 billion yuan, with a year-on-year increase of 15.02%. The net profit attributable to shareholders was 104 million yuan, down 5.26% year-on-year. The non-recurring net profit was 35.67 million yuan, a decrease of 51.98% year-on-year [6][8] - For Q1 2025, the company generated a revenue of 227 million yuan, up 7.30% year-on-year, but reported a net loss of 14.95 million yuan, a significant decline of 1661.37% year-on-year [6][7] - The company’s gross margin for 2024 was 37.44%, down 9.77 percentage points year-on-year, and the net margin was 7.88%, down 1.69 percentage points year-on-year [6] Business Segment Performance - Revenue from 3D printing customized products and technical services reached 689 million yuan, up 23.51% year-on-year, with a gross margin of 33.16% [6] - The aerospace sector generated 815 million yuan in revenue, a year-on-year increase of 33.08%, while the industrial sector saw a slight decline in revenue [6] Regional Performance - Domestic revenue was 1.245 billion yuan, up 13.01% year-on-year, while overseas revenue reached 80.96 million yuan, a significant increase of 58.47% year-on-year [6] Future Earnings Forecast - The company is projected to achieve net profits of 193 million yuan, 252 million yuan, and 299 million yuan for the years 2025, 2026, and 2027, respectively [9]

Group 1 - The AI mobile concept sector increased by 3.02%, ranking 10th among concept sectors, with 24 stocks rising, including Shenghong Technology, Plutec, and Nanchip Technology, which rose by 16.30%, 8.41%, and 6.80% respectively [1] - The AI mobile concept sector saw a net inflow of 279 million yuan from main funds, with 15 stocks receiving net inflows, and 5 stocks exceeding 30 million yuan in net inflow, led by iFlytek with a net inflow of 112 million yuan [2][3] - The top stocks in terms of net inflow ratio included Sixuan New Materials, Bawei Storage, and Plutec, with net inflow ratios of 8.74%, 8.46%, and 7.86% respectively [3][4] Group 2 - The top stocks in the AI mobile concept sector based on today's performance included iFlytek, ZTE, Bawei Storage, and Plutec, with respective daily price changes of 1.29%, 1.87%, 4.26%, and 8.41% [3][4] - The trading volume and turnover rates for key stocks in the AI mobile concept sector were highlighted, with iFlytek having a turnover rate of 1.38% and a main fund flow of 112.42 million yuan [3][4] - The overall market performance of the AI mobile concept sector reflects a positive trend, indicating potential growth opportunities within the sector [1][2]

Core Viewpoint - The Chinese innovative pharmaceutical industry is transitioning from imitation to original innovation, with significant growth in outbound transactions and a promising future for internationalization [4] Group 1: Market Performance - As of May 29, 2025, the Sci-Tech Innovation Board 100 Index (000698) rose by 1.63%, with notable increases in constituent stocks such as Borui Pharmaceutical (688166) up 9.66% and Zhixiang Jintai (688443) up 6.57% [3] - The Sci-Tech 100 Index ETF (588030) increased by 1.60%, with a latest price of 0.95 yuan and a turnover rate of 1.16%, totaling 71.56 million yuan in transactions [3] - Over the past year, the average daily transaction volume of the Sci-Tech 100 Index ETF reached 424 million yuan, ranking first among comparable funds [3] Group 2: Fund Growth and Performance - The Sci-Tech 100 Index ETF saw a significant increase in scale, growing by 94.45 million yuan over the past two weeks, ranking second among comparable funds [4] - In the past week, the ETF's shares increased by 99 million, also ranking first among comparable funds [5] - The ETF has experienced a net inflow of 71.08 million yuan over the last five trading days, indicating strong investor interest [5] Group 3: Financial Metrics - As of May 28, 2025, the Sci-Tech 100 Index ETF's net value increased by 19.94% over the past year, with a maximum monthly return of 27.67% since inception [5] - The ETF's management fee is 0.15% and the custody fee is 0.05%, making it the lowest among comparable funds [5] - The tracking error for the ETF over the past six months is 0.016%, indicating high tracking precision compared to similar funds [5] Group 4: Industry Insights - From the beginning of 2025 to the present, the total outbound transaction amount for innovative drugs has reached 45.5 billion USD, with upfront payments totaling 2.2 billion USD, suggesting a record year ahead [4] - Most domestic innovative drugs currently in the U.S. are in clinical stages, with significant potential for future growth as they progress towards commercialization [4]

Core Viewpoint - Xi'an Plater Technology Co., Ltd. is preparing for its 2024 annual shareholders' meeting, focusing on maintaining shareholder rights and ensuring orderly proceedings while proposing significant changes to its governance structure, including the cancellation of the supervisory board and amendments to the company charter [1][22]. Group 1: Meeting Procedures and Governance Changes - The company has established guidelines for the 2024 annual shareholders' meeting to confirm the identity of attendees and ensure orderly conduct [2][3]. - The meeting will include discussions on various proposals, including the cancellation of the supervisory board and amendments to the company charter, which require shareholder approval [22][23]. - The company will implement a combination of on-site and online voting for the proposals presented during the meeting [11][12]. Group 2: Financial Performance Overview - For the reporting period, the company achieved a revenue of approximately 1,325.57 million yuan, representing a year-on-year increase of 15.02% [27]. - The net profit attributable to shareholders was approximately 104.44 million yuan, reflecting a decrease of 5.26% compared to the previous year [27]. - The company's total assets reached approximately 7,285.69 million yuan, an increase of 11.65% year-on-year, while total liabilities rose by 38.06% to approximately 2,467.75 million yuan [27]. Group 3: Operational Insights - The company reported a significant increase in operating costs, which rose by 36.31% to approximately 829.34 million yuan, impacting overall profitability [27]. - Research and development expenses amounted to approximately 211.30 million yuan, accounting for 15.94% of total revenue, indicating a commitment to innovation [27][32]. - The company continues to focus on the aerospace sector, which constituted 61.45% of total revenue, highlighting its strategic market positioning [29].

证券代码：688333 证券简称：铂力特 西安铂力特增材技术股份有限公司 2024 年年度股东大会会议资料 二〇二五年六月 | | | 西安铂力特增材技术股份有限公司 2024 年年度股东大会会议资料 西安铂力特增材技术股份有限公司 2024 年年度股东大会会议须知 为了维护全体股东的合法权益，确保股东大会的正常秩序和议事效率，保证股 东大会的顺利进行，根据《中华人民共和国公司法》、《中华人民共和国证券法》、 《上市公司股东会规则》以及《西安铂力特增材技术股份有限公司章程》、《西安 铂力特增材技术股份有限公司股东大会议事规则》等相关规定，西安铂力特增材技 术股份有限公司（以下简称"公司"）特制定 2024 年年度股东大会会议须知： 一、为确认出席大会的股东或其代理人或其他出席者的出席资格，会议工作人 员将对出席会议者的身份进行必要的核对工作，请被核对者给予配合。出席会议的 股东及股东代理人须在会议召开前 30 分钟到会议现场办理签到手续，并请按规定 出示持股凭证、身份证明文件或法人单位证明、授权委托书等，经验证后方可出席 会议。 二、为保证本次大会的严肃性和正常秩序，切实维护股东的合法权益，务必请 出席大会的 ...

中信建投证券股份有限公司 关于西安铂力特增材技术股份有限公司 2024 年度持续督导跟踪报告 | 保荐人名称：中信建投证券股份有限 | 上市公司名称：西安铂力特增材技术股 | | | --- | --- | --- | | 公司 | 份有限公司 | | | 保荐代表人姓名：闫明 | 联系方式：010-56052594 联系地址：北京市朝阳区景辉街 16 号院 | | | | 号楼泰康大厦 层 1 | 11 | | 保荐代表人姓名：关天强 | 联系方式：010-56052386 | | | | 联系地址：北京市朝阳区景辉街 号院 16 | | | | 号楼泰康大厦 层 1 | 11 | 经中国证券监督管理委员会（简称"中国证监会"）"证监许可[2023]1444 号"批准，西安铂力特增材技术股份有限公司（简称"公司"或"铂力特"）向 特定对象发行股票并在科创板上市。本次公司发行新股的发行价为 94.50 元/股， 募集资金总额为 302,854.61 万元，扣除发行费用 2,115.02 万元后，实际募集资金 净额为 300,739.59 万元。本次公开发行股票于 2023 年 12 月 26 日在上海证券交 ...

证券代码：688333 证券简称：铂力特 公告编号：2025-026 西安铂力特增材技术股份有限公司 关于召开2024年年度股东大会的通知 召开地点：陕西省西安市高新区上林苑七路 1000 号西安铂力特增材技术股 份有限公司综合楼会议室 （五） 网络投票的系统、起止日期和投票时间。 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ? 股东大会召开日期：2025年6月9日 ? 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 一、 召开会议的基本情况 （一） 股东大会类型和届次 （二） 股东大会召集人：董事会 （三） 投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结 合的方式 （四） 现场会议召开的日期、时间和地点 召开日期时间：2025 年 6 月 9 日 15 点 00 分 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 6 月 9 日 至2025 年 6 月 9 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东 ...

证券代码：688333 证券简称：铂力特 公告编号：2025-026 西安铂力特增材技术股份有限公司 关于召开2024年年度股东大会的通知 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 一、 召开会议的基本情况 召开日期时间：2025 年 6 月 9 日 15 点 00 分 召开地点：陕西省西安市高新区上林苑七路 1000 号西安铂力特增材技术股 份有限公司综合楼会议室 （五） 网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 6 月 9 日 至2025 年 6 月 9 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 股东大会召开日期：2025年6月9日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 （二） 股东大会召集人：董事会 （三） 投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结 合的方式 （四） 现场会议召开的日期、时间和地点 东大会召开当日的交易时间段，即 9:1 ...

Investment Rating - The report suggests a positive outlook for the military industry, indicating a potential recovery in performance by 2025, with a focus on companies with order recovery expectations and performance support [2][10][44]. Core Insights - The military sector reported a total revenue of 764.903 billion yuan in 2024, a year-on-year increase of 1.16%. Key segments showing positive growth include shipbuilding, aerospace engines, and aviation [2][10]. - The net profit for the military sector decreased to 26.655 billion yuan in 2024, down 38.01% year-on-year, primarily due to lower downstream demand and price reductions for certain products [12][10]. - The first quarter of 2025 is expected to show signs of recovery, particularly in ground equipment and aerospace segments, with a projected increase in associated transaction amounts [2][29]. Summary by Sections 1. Industry Overview - The military sector's revenue growth was driven by shipbuilding (10.87% increase), aerospace engines (4.46% increase), and aviation (2.75% increase), while ground equipment and commercial aerospace saw significant declines [10][12]. - The report highlights a structural recovery in the military sector, with positive signals emerging from major companies regarding contract announcements and performance stabilization [2][38]. 2. Investment Strategy - The report recommends focusing on three main investment lines: 1. Traditional military sectors with expected order recovery, particularly in aerospace engines, shipbuilding, and aviation [2][44]. 2. New domains characterized by low-cost, intelligent, and systematic features, including precision-guided munitions and unmanned systems [2][44]. 3. Companies with asset integration expectations and competitive positions in military trade markets [2][44]. 3. Recommended Stocks - Traditional military direction: Recommended stocks include Aerospace Power, Aerospace Control, and Huayin Technology [3][45]. - New domain and new quality direction: Recommended stocks include High De Infrared, North Navigation, and Aerospace Rainbow [3][45]. - Reform and overseas direction: Recommended stocks include Guorui Technology and Construction Industry [3][45].

Investment Rating - The investment rating for the company is "Accumulate" [6] Core Views - The company achieved a revenue of 1.33 billion yuan in 2024, representing a year-on-year increase of 15.0%, driven by advancements in the aerospace sector and breakthroughs in consumer electronics and overseas market expansion [2][5] - The net profit attributable to shareholders for 2024 was 100 million yuan, a decrease of 5.3% year-on-year, primarily due to increased labor costs and higher fixed and R&D expenses associated with the company's expansion [2][3] - In Q1 2025, the company reported a revenue of 230 million yuan, up 7.3% year-on-year, but a net loss of 14.95 million yuan, attributed to significant R&D investments and rising employee compensation [2][3] Financial Performance Summary - The gross margin for 2024 was 37.4%, down 9.8 percentage points year-on-year, while the net margin was 7.9%, down 1.7 percentage points [3][6] - The company’s operating expenses ratio for 2024 was 32.8%, a decrease of 4.9 percentage points year-on-year, with the sales expense ratio increasing to 7.1% due to an expanded sales force [3][6] - Revenue forecasts for 2025-2027 are 1.76 billion, 2.42 billion, and 3.38 billion yuan respectively, with compound annual growth rates of 38% [5][6] Strategic Developments - The company has invested in Hualichuang Science, acquiring a 9% stake, which specializes in high-performance sensor solutions applicable in humanoid robots and other fields [3][20] - The company is expanding its 3D printing capabilities, particularly in aerospace and consumer electronics, which are expected to enhance its market position [4][5]